1. Home
  2. MXCT vs LANV Comparison

MXCT vs LANV Comparison

Compare MXCT & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • LANV
  • Stock Information
  • Founded
  • MXCT 1999
  • LANV 2015
  • Country
  • MXCT United States
  • LANV China
  • Employees
  • MXCT N/A
  • LANV N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LANV Blank Checks
  • Sector
  • MXCT Health Care
  • LANV Finance
  • Exchange
  • MXCT Nasdaq
  • LANV Nasdaq
  • Market Cap
  • MXCT 242.4M
  • LANV 275.9M
  • IPO Year
  • MXCT 2021
  • LANV N/A
  • Fundamental
  • Price
  • MXCT $2.04
  • LANV $2.30
  • Analyst Decision
  • MXCT Strong Buy
  • LANV
  • Analyst Count
  • MXCT 2
  • LANV 0
  • Target Price
  • MXCT $7.50
  • LANV N/A
  • AVG Volume (30 Days)
  • MXCT 473.0K
  • LANV 43.8K
  • Earning Date
  • MXCT 08-06-2025
  • LANV 08-25-2025
  • Dividend Yield
  • MXCT N/A
  • LANV N/A
  • EPS Growth
  • MXCT N/A
  • LANV N/A
  • EPS
  • MXCT N/A
  • LANV N/A
  • Revenue
  • MXCT $37,675,000.00
  • LANV $340,211,202.00
  • Revenue This Year
  • MXCT $8.36
  • LANV $11.74
  • Revenue Next Year
  • MXCT $20.14
  • LANV $11.11
  • P/E Ratio
  • MXCT N/A
  • LANV N/A
  • Revenue Growth
  • MXCT N/A
  • LANV N/A
  • 52 Week Low
  • MXCT $1.97
  • LANV $0.91
  • 52 Week High
  • MXCT $5.20
  • LANV $2.69
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 40.39
  • LANV 50.08
  • Support Level
  • MXCT $2.18
  • LANV $2.05
  • Resistance Level
  • MXCT $2.31
  • LANV $2.40
  • Average True Range (ATR)
  • MXCT 0.11
  • LANV 0.18
  • MACD
  • MXCT -0.01
  • LANV -0.02
  • Stochastic Oscillator
  • MXCT 18.52
  • LANV 45.76

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About LANV Lanvin Group Holdings Limited

Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.

Share on Social Networks: